Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation
TCTR20230119003Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial in Post-inflammatory hyperpigmentation (PIH), sponsored by Ramathibodi Hospital. Started Dec 2020; status: completed.
02
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on TCTR20230119003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230119003.